Chris Hoy’s Courageous Battle: The Track Legend’s Journey with Terminal Illness at 48

Chris Hoy’s Courageous Battle: The Track Legend’s Journey with Terminal Illness at 48

Sunday, October 20, 2024 at 8:43 AM

Six-time Olympic champion Chris Hoy has terminal cancer. According to doctors, the British former track cyclist still has several years to live. The 48-year-old track legend said this in an interview with The Sunday Times.

Hoy has been told by doctors that he has about two to four years to live. He announced earlier this year that he had been diagnosed with cancer. Hoy initially wanted to keep this private, but decided to share it with the outside world in February.

It was unclear for a long time what type of cancer it was, but Hoy has now announced that he was diagnosed with prostate cancer. The cancer has now spread to his bones. Tumors have been discovered in his shoulder, pelvis, hip, spine and ribs.

“No matter how unnatural it feels, this is nature,” Hoy says in a candid interview with The Sunday Times. “We are all born and we all die. I consider myself lucky that there is a medicine that allows me to postpone death for as long as possible. Most of the battle against cancer for me is not physical. It’s a mental thing.”

Chris Hoy (right) with another British track legend: Jason Kenny – photo: Cor Vos

Hoy is known as one of the greatest track cyclists of all time. During his illustrious career, he was crowned world champion no fewer than eleven times and won six Olympic titles. In 2013 he decided to hang up his track bike. In recent years, Hoy has mainly worked in the media, as an analyst and as the presenter of his own podcast.

Disaster also affects his wife
Hoy also indicated in the interview that his wife, Sarra, has a “very active and aggressive” form of multiple sclerosis (MS). This is a disorder of the central nervous system and probably an autoimmune condition, which can cause neurological disorders such as loss of strength. The course of the disease can vary greatly, as can the symptoms.

Facebook
Pinterest
Twitter
LinkedIn
Email

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *